Maven Securities LTD Oncocyte Corp Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $1.68 Million - $2.81 Million	-476,682 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.77 - $6.0 $1.07 Million - $1.7 Million	283,334 Added 146.54%	476,682 $2.73 Million
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $462,101 - $1.26 Million	193,348 New	193,348 $1.01 Million
Q3 2019 Nov 14, 2019	SELL	$1.59 - $2.51 $342,676 - $540,955	-215,520 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.49 - $5.45 $536,644 - $1.17 Million	215,520 New	215,520 $550,000

1.5M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $368M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.